Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review

Jay Bolden; Chris Knutsen; Jack Levin; Catherine Milne; Tina Morris; Ned Mozier; Ingo Spreitzer; Friedrich von Wintzingerode

doi:10.5731/pdajpst.2020.012187

Research ArticlePDA Paper

Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review

Jay Bolden, Chris Knutsen, Jack Levin, Catherine Milne, Tina Morris, Ned Mozier, Ingo Spreitzer and Friedrich von Wintzingerode

PDA Journal of Pharmaceutical Science and Technology September 2020, 74 (5) 602-611; DOI: https://doi.org/10.5731/pdajpst.2020.012187

Jay Bolden

1Eli Lilly and Company;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: jbolden@lilly.com

Chris Knutsen

2Bristol Myers Squibb;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jack Levin

3University of California School of Medicine, San Francisco, CA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Milne

4European Directorate for the Quality of Medicines and HealthCare, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tina Morris

5American Association of Pharmaceutical Scientists;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ned Mozier

6Pfizer;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ingo Spreitzer

7Paul-Ehrlich-Institute, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Friedrich von Wintzingerode

8Roche-Genentech

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 74 no. 5 602-611

DOI

https://doi.org/10.5731/pdajpst.2020.012187

PubMed

32817324

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online October 5, 2020.

Article Versions

previous version (August 14, 2020 - 07:58).
You are viewing the most recent version of this article.

Author Information

Jay Bolden¹,*,
Chris Knutsen²,
Jack Levin³,
Catherine Milne⁴,
Tina Morris⁵,
Ned Mozier⁶,
Ingo Spreitzer⁷ and
Friedrich von Wintzingerode⁸,ⁱ

¹Eli Lilly and Company;
²Bristol Myers Squibb;
³University of California School of Medicine, San Francisco, CA;
⁴European Directorate for the Quality of Medicines and HealthCare, France;
⁵American Association of Pharmaceutical Scientists;
⁶Pfizer;
⁷Paul-Ehrlich-Institute, Germany; and
⁸Roche-Genentech

↵*Corresponding Author: Global Quality Laboratories Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN 46285; E-mail: jbolden{at}lilly.com

View Full Text

Cited By...

4 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Outstanding Contributions of LAL Technology to Pharmaceutical and Medical Science: Review of Methods, Progress, Challenges, and Future Perspectives in Early Detection and Management of Bacterial Infections and Invasive Fungal Diseases

Hiroshi Tamura, Johannes Reich, Isao Nagaoka

Biomedicines 2021 9 5
Recombinant bacterial endotoxin testing: a proven solution

Brendan Tindall, Dogan Demircioglu, Thomas Uhlig

BioTechniques 2021 70 5
International Horseshoe Crab Conservation and Research Efforts: 2007- 2020

Thomas J. Novitsky

2022
LAL Non-Endotoxin Reactivity - Surprisingly Non-specific

Kevin Williams

EJPPS EUROPEAN JOURNAL OF PARENTERAL AND PHARMACEUTICAL SCIENCES 2022

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 74, Issue 5

September/October 2020

Table of Contents
Index by Author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 9 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review

Jay Bolden, Chris Knutsen, Jack Levin, Catherine Milne, Tina Morris, Ned Mozier, Ingo Spreitzer, Friedrich von Wintzingerode

PDA Journal of Pharmaceutical Science and Technology Sep 2020, 74 (5) 602-611; DOI: 10.5731/pdajpst.2020.012187

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review